Oasis, Kobayashi Pharmaceutical’s largest shareholder, calls for a “competitive process” as the company considers going private

Kobayashi Pharmaceutical is reportedly considering going private under NSSK and UK investment fund CVC Capital Partners, with largest shareholder Oasis seeking a competitive process.

Full text unavailableWorking from the headline and excerpt

sources corroborateOutlets reporting the same event

companies linkedAcross 0 themes, second pass

The story

Kobayashi Pharmaceutical is reportedly considering going private and moving under the control of NSSK and UK investment fund CVC Capital Partners.

The move has been discussed based on information from people familiar with the matter, but specific transaction terms and the timeline have not been disclosed.

At a glance

CompanyKobayashi Pharmaceutical

Report date24 September

IntegrationNSSK and CVC to take control

PurposeConsidering going private

RequestsOasis seeks a competitive process

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

www.bloomberg.comNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.